September 22 - 25, 2022   Chicago Marriott Downtown Magnificent Mile

Registration Information

Online registration is now closed. -

Walk-in registrations are welcome starting at 8:00 a.m. on Thursday, September 22. We also have a limited number of lunch tickets tickets available for purchase at the registration desk.

Advance registration is encouraged, as space and materials are limited. The registration fee includes conference tuition, CME credits, digital materials, four breakfasts, refreshment breaks and an evening reception. You must make separate hotel arrangements if you plan to stay overnight at the hotel.


Type Discounted (through August 1) Regular (After August 1)
Physician$625 $725
Fellow/Student/Trainee$325 $425
Nurse/Nurse Practitioner/Physician Assistant $325 $425
Industry $825 $925


NOTE: On-line registration will close Monday, September 19 at noon.


Lunch Ticket $30/day

Registrants may check in for the conference on the 7th floor of the Chicago Marriott Downtown Magnificent Mile beginning at 8:00 a.m. on Thursday, September 22. Walk-in registrations are also welcome beginning at 8:00 a.m. on Thursday, September 22.

Digital Materials

Registrants will be able to view and/or download general session PowerPoint presentations via the Lynn Sage Breast Cancer Symposium website the week before the symposium and view updated presentations during and after the live presentations.

Refund/Cancellation Policy

Registration fees less a $50 administrative handling fee are refundable if a written request is received on or before August 30, 2022. Please include your registration ID number when requesting a refund. No refunds will be granted after August 30, 2022; however, you may transfer your registration to a colleague. No refunds will be given for lunch.


To submit requests or request further information, contact the Lurie Cancer Center at 312.503.7809 or e-mail us at

Related Links

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lynn Sage Breast Cancer Foundation

Sponsored by

Feinberg School of Medicine

Registration Desk

Learning Objectives

  1. Describe the role of artificial intelligence in breast imaging and pathology.
  2. Discuss advances in the evaluation, screening, and management of women at increased risk for breast cancer development.
  3. Cite the current status of adjuvant and neoadjuvant therapy for ER+, HER2+ and triple negative breast cancer.
  4. Restate how local therapy has evolved to better tailor treatment to disease extent and biology.

Target Audience

The target audience for this activity includes medical oncologists, radiation oncologists, surgical oncologists, fellows in training, oncology nurses and allied health professionals in the field of breast cancer.

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 21.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Credits

The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits(s)™ from organizations accredited by the ACCME.

Faculty Disclosure

Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus. All faculty will be disclosing.

© 2022 Robert H. Lurie Comprehensive Cancer Center